These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 33387249)

  • 41. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
    Purohit P; Dash JJ; Muya JT; Meher BR
    J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.
    Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B
    Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.
    Marinho EM; Batista de Andrade Neto J; Silva J; Rocha da Silva C; Cavalcanti BC; Marinho ES; Nobre Júnior HV
    Microb Pathog; 2020 Nov; 148():104365. PubMed ID: 32619669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring the Therapeutic Potential of
    Ali MA; Sheikh H; Yaseen M; Faruqe MO; Ullah I; Kumar N; Bhat MA; Mollah MNH
    Molecules; 2024 May; 29(11):. PubMed ID: 38893400
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2024; 21(3):73-89. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 M
    More-Adate P; Lokhande KB; Swamy KV; Nagar S; Baheti A
    Comput Biol Med; 2022 Aug; 147():105679. PubMed ID: 35667152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M
    Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F
    Eur Biophys J; 2024 Aug; 53(5-6):277-298. PubMed ID: 38907013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19.
    Sisakht M; Solhjoo A; Mahmoodzadeh A; Fathalipour M; Kabiri M; Sakhteman A
    Comput Biol Med; 2021 Sep; 136():104686. PubMed ID: 34340125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
    Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
    J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
    Ghosh A; Chakraborty M; Chandra A; Alam MP
    J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m
    Badavath VN; Kumar A; Samanta PK; Maji S; Das A; Blum G; Jha A; Sen A
    J Biomol Struct Dyn; 2022 Apr; 40(7):3110-3128. PubMed ID: 33200681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.
    Mandour YM; Zlotos DP; Alaraby Salem M
    J Biomol Struct Dyn; 2022 Mar; 40(5):2327-2338. PubMed ID: 33094680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.
    Kandeel M; Abdelrahman AHM; Oh-Hashi K; Ibrahim A; Venugopala KN; Morsy MA; Ibrahim MAA
    J Biomol Struct Dyn; 2021 Sep; 39(14):5129-5136. PubMed ID: 32597315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QSAR Modeling of SARS-CoV M
    Alves VM; Bobrowski T; Melo-Filho CC; Korn D; Auerbach S; Schmitt C; Muratov EN; Tropsha A
    Mol Inform; 2021 Jan; 40(1):e2000113. PubMed ID: 33405340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular docking and simulation studies of natural compounds of
    Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
    J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease.
    Choudhury C
    J Biomol Struct Dyn; 2021 Jul; 39(10):3733-3746. PubMed ID: 32452282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL
    Liu WS; Li HG; Ding CH; Zhang HX; Wang RR; Li JQ
    Aging (Albany NY); 2021 Mar; 13(5):6258-6272. PubMed ID: 33678621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.